Nasdaq
Orion Corporation: Managers' transactions - Timo Maasilta
03-05-2018
ORION CORPORATION MANAGERS' TRANSACTIONS 3 MAY 2018 at 11.40 EETS
Orion Corporation: Managers' transactions - Timo Maasilta
Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No 596/2014, regarding transactions with shares and linked securities in Orion Corporation made by managers and their closely associated persons.
| Person subject to the notification requirement | ||
| Name: | Maasilta, Timo | |
| Position: | Member of the Board/Deputy member | |
| Initial Notification | ||
| Reference number: | 74370029VAHCXDR7B745_20180503092946_7 | |
| Issuer | ||
| Name: | Orion Oyj | |
| LEI: | 74370029VAHCXDR7B745 | |
| Transaction details | ||
| Transaction date: | 2018-05-02 | |
| Venue: | NASDAQ HELSINKI LTD (XHEL) | |
| Nature of the transaction: | Receipt of a Share-Based Incentive or Remuneration | |
| Instrument: | Share | |
| ISIN: | FI0009014377 | |
| Volume: | 913 | |
| Unit price: | 0.00000 | |
| Aggregated transactions | ||
| Volume: | 913 | |
| Volume weighted average price: | 0.00000 | |
Orion Corporation
| Timo Lappalainen | Olli Huotari |
| President and CEO | SVP, Corporate Functions |
Publisher:
Orion Corporation
Communications
Orionintie 1A, FI-02200 Espoo
www.orion.fi
Latest Health & Supplement Reviews
- YuSleep Reviews (EXPOSED) Doctor Explains Deep Sleep Benefits, Hidden Risks & Real Consumers Results In 2026
- Neuro Energizer Reviews and Complaints 2026: How This Neuro-Sonic Breakthrough Is Reshaping Cognitive Therapy, Memory & Daily Focus
- Gluco6 Reviews and Complaints (March 2026) Real User Data on Natural Blood Sugar Balance and Glucose Stability